Landmark Study May Pave the Way for Personalized Treatment of Lupus and Other Complex Autoimmune Diseases

Source: Baylor Scott & White Research Institute

Congratulations to our LRI Scientific Advisory Board member and researcher at Baylor Institute for Immunology Research Dr. Virginia Pascual for publishing new research that may dramatically improve drug development for systemic lupus erythematosus patients. The work was funded in part by the Alliance for Lupus Research. Her paper will be published April 21 in Cell, a highly prestigious scientific journal among biologists.

“The results included in this paper provide an explanation for why clinical trials fail in lupus, and opens the door for true personalized approaches to drug discovery and treatment in this disease,” Dr. Pascual said.

Click to read more.